GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to treat Idiopathic Intracranial Hypertension: a scoping review

Study Design: Scoping review. Objectives: To map and synthesize the evidence regarding glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists (GLP-1/GIP RAs) in the treatment of Idiopathic Intracranial Hypertension (IIH). Methods: Quantitative articles, clinical studies addressing the concept of GLP-1 RAs and GLP-1/GIP RAs in IIH patients will be included. The search strategies will be applied to the Cochrane Library, Embase, MEDLINE, LILACS, Scopus, Web of Science Core Collection, and LIVIVO. Additionally, sources of gray literature will be searched. We will also look for studies using platforms and artificial intelligence tools, platforms of register of preprints and register of trials protocols. The studies will be selected by four authors, accordingly to the eligibility criteria.

Authors

Publication Details

Journal
Open Science Framework
Published
2026-07-27
DOI
https://doi.org/10.17605/osf.io/aqjzn
Primary Topic
Cerebral Venous Sinus Thrombosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to treat Idiopathic Intracranial Hypertension: a scoping review

Graziela De Luca Canto, Franz Jooji Onishi, Helena Polmann, Patrícia Pauletto et al.
Open Science Framework
Cerebral Venous Sinus Thrombosis
article

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to treat Idiopathic Intracranial Hypertension: a scoping review

Graziela De Luca Canto, Franz Jooji Onishi, Helena Polmann, Patrícia Pauletto, Antônio Santos de Araújo, Lee Sl, Vladimir Tonello de [UNIFESP] Vasconcelos, Ana Camila de Castro Gandolfi, Virginia Fernandes Moça Trevisani
article en

Abstract

Study Design: Scoping review. Objectives: To map and synthesize the evidence regarding glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists (GLP-1/GIP RAs) in the treatment of Idiopathic Intracranial Hypertension (IIH). Methods: Quantitative articles, clinical studies addressing the concept of GLP-1 RAs and GLP-1/GIP RAs in IIH patients will be included. The search strategies will be applied to the Cochrane Library, Embase, MEDLINE, LILACS, Scopus, Web of Science Core Collection, and LIVIVO. Additionally, sources of gray literature will be searched. We will also look for studies using platforms and artificial intelligence tools, platforms of register of preprints and register of trials protocols. The studies will be selected by four authors, accordingly to the eligibility criteria.

Open Science Framework
Quality Education
Openalex Percentile: Top 9%
Cerebral Venous Sinus Thrombosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to treat Idiopathic Intracranial Hypertension: a scoping review — Graziela De Luca Canto, Franz Jooji Onishi, et al. · Open Science Framework (2026) | TGRS Research Map | TGRS